Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/12/970   
Active ingredient: 6-ethynyl-1-(pentan-3-yl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: Pharma Gateway AB
Johanneslundsvägen 2, Hammarby, 194 61 Upplands Väsby, Stockholms Lan, Sverige

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
7/03/2012 Orphan designation EMA/OD/138/11 (2012)1535 of 5/03/2012
4/02/2015 Transfer of orphan designation EMA/OD/138/11/T/01 (2015)639 of 2/02/2015
13/06/2017 Change of name and/or address of sponsor